NO20014603L - Tienopyrimidinforbindelser, deres fremstilling og anvendelse - Google Patents
Tienopyrimidinforbindelser, deres fremstilling og anvendelseInfo
- Publication number
- NO20014603L NO20014603L NO20014603A NO20014603A NO20014603L NO 20014603 L NO20014603 L NO 20014603L NO 20014603 A NO20014603 A NO 20014603A NO 20014603 A NO20014603 A NO 20014603A NO 20014603 L NO20014603 L NO 20014603L
- Authority
- NO
- Norway
- Prior art keywords
- tienopyrimidine
- compounds
- preparation
- tienopyrimidine compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7937199 | 1999-03-24 | ||
| JP2000018019 | 2000-01-25 | ||
| PCT/JP2000/001777 WO2000056739A1 (en) | 1999-03-24 | 2000-03-23 | Thienopyrimidine compounds, their production and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014603D0 NO20014603D0 (no) | 2001-09-21 |
| NO20014603L true NO20014603L (no) | 2001-11-26 |
Family
ID=26420391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014603A NO20014603L (no) | 1999-03-24 | 2001-09-21 | Tienopyrimidinforbindelser, deres fremstilling og anvendelse |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6340686B1 (no) |
| EP (1) | EP1163244B1 (no) |
| JP (1) | JP3240293B2 (no) |
| KR (2) | KR100533483B1 (no) |
| CN (1) | CN1349536A (no) |
| AR (1) | AR023152A1 (no) |
| AT (1) | ATE261449T1 (no) |
| AU (1) | AU764019B2 (no) |
| BR (1) | BR0009297A (no) |
| CA (1) | CA2368108C (no) |
| CZ (1) | CZ294747B6 (no) |
| DE (1) | DE60008862T2 (no) |
| DK (1) | DK1163244T3 (no) |
| ES (1) | ES2212992T3 (no) |
| HK (1) | HK1042495B (no) |
| HU (1) | HUP0200550A3 (no) |
| ID (1) | ID30393A (no) |
| IL (1) | IL145549A (no) |
| MX (1) | MXPA01009566A (no) |
| MY (1) | MY124726A (no) |
| NO (1) | NO20014603L (no) |
| NZ (1) | NZ514737A (no) |
| OA (1) | OA11920A (no) |
| PL (1) | PL351202A1 (no) |
| PT (1) | PT1163244E (no) |
| SK (1) | SK13552001A3 (no) |
| TW (1) | TWI225863B (no) |
| WO (1) | WO2000056739A1 (no) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
| AU2001234188A1 (en) * | 2000-02-29 | 2001-09-12 | Takeda Chemical Industries Ltd. | Processes for the production of thienopyrimidine derivatives |
| CA2406832A1 (en) * | 2000-04-13 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Preventives/remedies for alzheimer's disease |
| AU2001264264A1 (en) * | 2000-06-14 | 2001-12-24 | Takeda Chemical Industries Ltd. | Sustained release compositions |
| EP1319409A4 (en) * | 2000-09-22 | 2006-05-03 | Takeda Pharmaceutical | SOLID PREPARATIONS |
| WO2002043766A1 (en) * | 2000-11-29 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Medicinal compositions and process for producing the same |
| AU2002221139A1 (en) * | 2000-12-15 | 2002-06-24 | Takeda Chemical Industries Ltd. | Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof |
| US20040116522A1 (en) * | 2001-03-30 | 2004-06-17 | Yutaka Yamagata | Medicinal solutions |
| JP2005500352A (ja) | 2001-08-02 | 2005-01-06 | ニューロクライン バイオサイエンシーズ， インコーポレイテッド | ゴナドトロピン放出ホルモンレセプター（ＧｎＲＨ）アンタゴニストとしての１，２，４−トリアジン−３，５−ジオン |
| AU2002324586B2 (en) | 2001-08-02 | 2008-04-24 | Neurocrine Biosciences, Inc. | 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| EP1412363A1 (en) | 2001-08-02 | 2004-04-28 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists |
| MXPA04000985A (es) | 2001-08-02 | 2005-02-17 | Neurocrine Biosciences Inc | Piridin-4-onas sustituidas y su uso como antagonistas del receptor de hormona de liberacion de gonadotropina. |
| EP1411941A2 (en) | 2001-08-02 | 2004-04-28 | Neurocrine Biosciences, Inc. | Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| US7569570B2 (en) * | 2002-01-30 | 2009-08-04 | Takeda Pharmaceutical Company Limited | Thienopyrimidines, process for preparing the same and use thereof |
| EP1495768A4 (en) * | 2002-04-12 | 2007-12-05 | Takeda Pharmaceutical | MEANS FOR THE PREVENTION / TREATMENT OF HITZEWALLUNGEN |
| EP1532154B1 (en) * | 2002-08-21 | 2008-01-16 | AstraZeneca AB | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| EP1591446B1 (en) | 2003-01-29 | 2013-03-06 | Takeda Pharmaceutical Company Limited | Thienopyrimidine compounds and use thereof |
| GB0307777D0 (en) | 2003-04-04 | 2003-05-07 | Medical Res Council | Conjugate compounds |
| WO2006044902A2 (en) * | 2004-10-18 | 2006-04-27 | Bwt Property, Inc. | A solid-state lighting apparatus for navigational aids |
| NZ566038A (en) * | 2005-07-22 | 2011-06-30 | Takeda Pharmaceutical | The use of thieno(2,3-d)pyrimidine-2,4-dione derivatives which are gonadotropin releasing hormone (GnRH) antagonists as premature ovulation preventive agent |
| JPWO2010026993A1 (ja) | 2008-09-03 | 2012-02-02 | 武田薬品工業株式会社 | 製剤における吸収性改善方法および吸収性が改善された製剤 |
| WO2013129879A1 (en) * | 2012-02-28 | 2013-09-06 | Sk Chemicals Co., Ltd. | Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same |
| ES2913753T3 (es) * | 2012-09-28 | 2022-06-06 | Takeda Pharmaceuticals Co | Forma cristalina de 1-(4-1-(2,6-difluorobencil)-5-dimetilaminometil-3-(6-metoxipiridazin-3-il)-2,4-dioxo-1,2,3,4-tetrahidrotieno(2,3-d)-pirimidin-6il)fenil)-3-metoxiurea |
| EP3263110B1 (en) * | 2015-02-26 | 2023-05-10 | Takeda Pharmaceutical Company Limited | A tablet comprising a methoxyurea derivative and mannitol particles |
| BR112019006228A2 (pt) | 2016-09-30 | 2019-06-18 | Myovant Sciences Gmbh | tratamento de câncer de próstata |
| HRP20220708T4 (hr) | 2016-09-30 | 2025-04-25 | Sumitomo Pharma Switzerland Gmbh | Postupci liječenja fibroida maternice i endometrioze |
| KR101973074B1 (ko) * | 2018-11-30 | 2019-04-26 | 주식회사 티움바이오 | 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물 |
| EP4004001B1 (en) * | 2019-07-29 | 2025-09-03 | Sunshine Lake Pharma Co., Ltd. | Substituted pyrimidinedione compounds and uses thereof |
| EP4041739A1 (en) | 2019-10-10 | 2022-08-17 | Myovant Sciences GmbH | Crystalline forms of n-(4-(1-(2,6-difluorobenzyl)-5- ((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo- 1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'- methoxyurea |
| CN111574534B (zh) * | 2020-05-25 | 2021-06-04 | 东莞市东阳光新药研发有限公司 | 苯基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途 |
| CN111925379B (zh) * | 2020-07-31 | 2022-02-15 | 广东东阳光药业有限公司 | 含氮杂芳基取代的嘧啶二酮类化合物及其用途 |
| CN111909168B (zh) * | 2020-07-31 | 2022-02-01 | 广东东阳光药业有限公司 | 含氮杂环基取代的嘧啶二酮类化合物及其用途 |
| CN113754679B (zh) * | 2020-09-09 | 2023-04-07 | 广东东阳光药业有限公司 | 取代的嘧啶二酮类化合物及其用途 |
| CN112047957B (zh) * | 2020-09-09 | 2022-02-01 | 广东东阳光药业有限公司 | 取代的嘧啶二酮类化合物及其用途 |
| CN113563304B (zh) * | 2020-12-30 | 2022-06-28 | 上海博志研新药物技术有限公司 | 瑞卢戈利中间体及其制备方法 |
| CN115260211B (zh) * | 2021-04-29 | 2024-02-06 | 长春金赛药业有限责任公司 | 含噻吩稠环类衍生物、药物组合物及其制备方法和应用 |
| CN113717149A (zh) * | 2021-09-29 | 2021-11-30 | 成都伊诺达博医药科技有限公司 | 一种瑞卢戈利关键中间体及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
| UY23948A1 (es) * | 1995-02-08 | 2001-10-25 | Takeda Chemical Industries Ltd | Derivados de anillos condensados de tiofeno su producción y uso. |
| US5627786A (en) * | 1995-02-10 | 1997-05-06 | Micron Quantum Devices, Inc. | Parallel processing redundancy scheme for faster access times and lower die area |
| EP0816316A4 (en) * | 1995-03-10 | 1999-06-02 | Nitto Chemical Industry Co Ltd | Process for producing 1,2-ethanediol derivatives |
-
2000
- 2000-03-08 TW TW089104127A patent/TWI225863B/zh not_active IP Right Cessation
- 2000-03-21 MY MYPI20001112 patent/MY124726A/en unknown
- 2000-03-23 KR KR10-2000-7011511A patent/KR100533483B1/ko not_active Expired - Fee Related
- 2000-03-23 CZ CZ20013419A patent/CZ294747B6/cs not_active IP Right Cessation
- 2000-03-23 BR BR0009297-5A patent/BR0009297A/pt not_active IP Right Cessation
- 2000-03-23 IL IL14554900A patent/IL145549A/xx not_active IP Right Cessation
- 2000-03-23 KR KR10-2000-7011508A patent/KR100370981B1/ko not_active Expired - Fee Related
- 2000-03-23 SK SK1355-2001A patent/SK13552001A3/sk unknown
- 2000-03-23 PT PT00911308T patent/PT1163244E/pt unknown
- 2000-03-23 WO PCT/JP2000/001777 patent/WO2000056739A1/en not_active Ceased
- 2000-03-23 CA CA002368108A patent/CA2368108C/en not_active Expired - Fee Related
- 2000-03-23 NZ NZ514737A patent/NZ514737A/en unknown
- 2000-03-23 HK HK02104325.6A patent/HK1042495B/en not_active IP Right Cessation
- 2000-03-23 MX MXPA01009566A patent/MXPA01009566A/es active IP Right Grant
- 2000-03-23 OA OA1200100243A patent/OA11920A/en unknown
- 2000-03-23 DE DE60008862T patent/DE60008862T2/de not_active Expired - Lifetime
- 2000-03-23 JP JP2000087051A patent/JP3240293B2/ja not_active Expired - Fee Related
- 2000-03-23 CN CN00807210A patent/CN1349536A/zh active Pending
- 2000-03-23 PL PL00351202A patent/PL351202A1/xx not_active Application Discontinuation
- 2000-03-23 ID IDW00200102298A patent/ID30393A/id unknown
- 2000-03-23 AT AT00911308T patent/ATE261449T1/de not_active IP Right Cessation
- 2000-03-23 ES ES00911308T patent/ES2212992T3/es not_active Expired - Lifetime
- 2000-03-23 AU AU33262/00A patent/AU764019B2/en not_active Ceased
- 2000-03-23 EP EP00911308A patent/EP1163244B1/en not_active Expired - Lifetime
- 2000-03-23 DK DK00911308T patent/DK1163244T3/da active
- 2000-03-23 HU HU0200550A patent/HUP0200550A3/hu unknown
- 2000-03-24 AR ARP000101320A patent/AR023152A1/es not_active Application Discontinuation
- 2000-05-16 US US09/571,215 patent/US6340686B1/en not_active Expired - Lifetime
-
2001
- 2001-09-21 NO NO20014603A patent/NO20014603L/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015156L (no) | 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse | |
| NO20014603D0 (no) | Tienopyrimidinforbindelser, deres fremstilling og anvendelse | |
| NO20021449L (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse | |
| NO20024742D0 (no) | Heterocykliske forbindelser, deres fremstilling og anvendelse | |
| NO20015113D0 (no) | Nye forbindelser, deres fremstilling og anvendelse | |
| NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
| NO20011956L (no) | Substituerte fenylderivater, deres fremstilling og anvendelse | |
| DK1073672T3 (da) | Antipicornavirale forbindelser, deres fremstilling og anvendelse | |
| NO20024175D0 (no) | Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme | |
| DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
| NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| DK1161434T3 (da) | Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse | |
| NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
| DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
| NO20023146D0 (no) | Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse | |
| NO20020156D0 (no) | Titanavledede forbindelser, fremstilling og anvendelse derav | |
| NO20022022D0 (no) | N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
| NO20024107L (no) | Tienopyridin derivater, deres fremstilling og anvendelse | |
| NO20006479D0 (no) | Tienopyridinforbindelser, deres fremstilling og anvendelse | |
| NO20025209L (no) | Cyklipostiner, deres fremstilling og anvendelse | |
| NO20001782D0 (no) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
| NO996156L (no) | Substituerte cykloheptener, deres fremstilling og anvendelse | |
| NO20012802D0 (no) | Benzofuranderivater, deres fremstilling og anvendelse | |
| NO20011921L (no) | Sulfidoamidokarboksylsyre, deres fremstilling og anvendelse | |
| DK1177196T3 (da) | Heteroaryldiazabicycloalkaner, deres fremstilling og anvendelse |